PRFX:NASDAQ, PainReform Ltd.

Why PRFX stock fell on November 16

PainReform Ltd. fell 11.2% on Monday, November 16, 2026, on 86,264 shares. No headline about PRFX came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

PRFX stock overview

PainReform Ltd. (PRFX:NASDAQ) closed at $0.695 on November 16, 2026, down 11.22% on the day. The stock trades 91.3% below its 52-week high of $7.95 and 8.4% above its 52-week low of $0.641. Over the past year, it lost 84.3%. PainReform Ltd. is part of the Health Care sector.

Key figures

Price
$0.695
Day change
-11.22%
Volume
86,264
Average volume
232,553
Market cap
2M+
52-week range
$0.641 – $7.95
50-day average
$0.855
200-day average
$1.66

Price action over the past year

In 252 trading sessions since November 14, 2025, PRFX closed higher on 89 days (35%). Its best day was May 29, 2026 (+118.98%) and its worst was June 1, 2026 (-32.67%). The stock moved 10% or more in a single session 27 times. It opened at least 5% above the previous day's high 8 times.

Recent signals

PRFX news

About PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Similar stocks

Find more stocks like PRFX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.